Marksans Pharma board to consider conversion of warrants and issue

10 Dec 2012 Evaluate

Marksans Pharma has informed that a meeting of the board of directors of the company will be held on December 14, 2012 to consider conversion of warrants and issue and allot in lieu thereof 1,75,00,000 equity shares of Rs. 1 each to Mark Saldanha, Promoter of the company on preferential allotment basis.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×